Search Browse Earnings

Calidi Biotherapeutics, Inc. — SlamSEC

Calidi Biotherapeutics, Inc.

NYSE:CLDIOTC:CLDWW

Biological Products, (No Diagnostic Substances)·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$45,000

FY 2023

Adj. EBITDA

-$28.6M

-63555.6% margin

FY 2024

Net Income

-$29.2M

-64924.4% margin

FY 2024

EPS (Diluted)

-$17.33

FY 2024

Stock Price

$0.35

-3.6%

2026-03-10

52W Range

$0.34 – $19.20

P/E Ratio

-0.0x

Market Cap

$2.5M

Cash

$9.6M

FY 2024

Total Debt

$2.1M

FY 2024

Net Cash

$7.5M

FY 2024

Enterprise Value

-$5.0M

Debt / EBITDA

0.3x

FY 2023

EV / EBITDA

0.2x

Employees

—

CEO

Poma Eric E

CFO

Jackson Andrew C.